Validation of an algorithm to identify antiretroviral-naïve status at time of entry into a large, observational cohort of HIV-infected patients-Reference-Cited by-同舟云学术

Validation of an algorithm to identify antiretroviral-naïve status at time of entry into a large, observational cohort of HIV-infected patients

Published:2013-07-09 Issue:9 Volume:22 Page:1019-1025
ISSN:1053-8569
Container-title:Pharmacoepidemiology and Drug Safety
language:en
Short-container-title:Pharmacoepidemiol Drug Saf

Author:

Gandhi Neel R.¹²,Tate Janet P.³,Rodriguez-Barradas Maria C.⁴,Rimland David⁵,Goetz Matthew Bidwell⁶,Gibert Cynthia⁷,Brown Sheldon T.⁸,Mattocks Kristin⁹,Justice Amy C.³

Affiliation:

1. Division of General Internal Medicine; Albert Einstein College of Medicine and Montefiore Medical Center; Bronx NY USA

2. Departments of Epidemiology, Global Health, and Infectious Diseases, Rollins School of Public Health; Emory University; Atlanta GA USA

3. Section of General Internal Medicine, Department of Medicine; Yale University School of Medicine and VA Connecticut Healthcare System; New Haven CT USA

4. Infectious Disease Section and Department of Medicine; Michael E. DeBakey VA Medical Center and Baylor College of Medicine; Houston TX USA

5. Infectious Diseases Section, Department of Medicine; Emory University School of Medicine and Atlanta VA Medical Center; Atlanta GA USA

6. Section of Infectious Diseases; VA Greater Los Angeles Healthcare System and David Geffen School of Medicine at UCLA; Los Angeles CA USA

7. Section of Infectious Diseases; Washington DC VA Medical Center and George Washington University Medical Center; Washington District of Columbia USA

8. Infectious Disease Section, Department of Medicine; James J. Peters VA Medical Center and Mt. Sinai School of Medicine; New York NY USA

9. Quantitative Health Sciences and Psychiatry; VA Central Western Massachusetts Health Care System, Leeds, MA and University of Massachusetts Medical Center; Worcester MA USA

Publisher

Wiley

Subject

Pharmacology (medical),Epidemiology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/pds.3476/fullpdf

Reference24 articles.

1. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators;Palella;N Engl J Med,1998

2. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team;Hammer;N Engl J Med,1997

3. Highly active antiretroviral therapy and the incidence of HIV-1-associated nephropathy: a 12-year cohort study;Lucas;AIDS,2004

4. Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies;Egger;Lancet,2002

5. Long-term effectiveness of potent antiretroviral therapy in preventing AIDS and death: a prospective cohort study;Sterne;Lancet,2005

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Polypharmacy and frailty among persons with HIV;AIDS Care;2020-09-03

2. Trends in Comorbid Conditions Among Medicaid Enrollees With HIV;Open Forum Infectious Diseases;2019-03-10

3. Tenofovir-Associated Bone Adverse Outcomes among a US National Historical Cohort of HIV-Infected Veterans: Risk Modification by Concomitant Antiretrovirals;Infectious Diseases and Therapy;2018-02-28

4. Cardiovascular outcomes among HIV-infected veterans receiving atazanavir;AIDS;2017-09-24

5. Risk of liver decompensation with cumulative use of mitochondrial toxic nucleoside analogues in HIV/hepatitis C virus coinfection;Pharmacoepidemiology and Drug Safety;2017-07-19